title: Radiocopper for the imaging of copper metabolism.
abstract: The redox-active transition metal copper is an essential trace element for growth and development and serves as a structural or catalytic cofactor for many enzymes in a range of physiological processes. Mammalian copper homeostasis is tightly regulated, and an imbalance in copper metabolism is implicated in various pathological disorders. Radioactive copper isotopes, in particular (64) Cu (t1/2  = 12.7 h) and (67) Cu (t1/2  = 62.01 h), have made important contributions to the understanding of copper metabolism in health and disease. This review gives a brief account of how radiolabelled copper(II) salts and bioreductive copper complexes have been used to trace copper uptake, transport and efflux in vitro and in vivo. Recently, positron emission tomography (PET) has emerged as a noninvasive tool to image copper metabolism in living subjects and (64) Cu-PET is investigated for the study of copper-related neurological disorders, genetic diseases and cancer.
authors.affiliation: Division of Imaging Sciences & Biomedical Engineering, King's College London, St. Thomas' Hospital, London, UK; Chemistry Research Laboratory, University of Oxford, Oxford, UK.
authors.forename: Rebekka
authors.initials: R
authors.lastname: Hueting
mesh_terms: D000818:Animals; D027682:Cation Transport Proteins / Q000378:metabolism; D003300:Copper / Q000378:metabolism*; D003301:Copper Radioisotopes; D006801:Humans; D057054:Molecular Imaging / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology
chemical_list: D027682:Cation Transport Proteins; D003301:Copper Radioisotopes; D003300:Copper
keywords: Alzheimer's disease; Wilson's disease; copper metabolism; radiocopper; tumour imaging